US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Market Research Reports & Industry Analysis

The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine.
In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides. In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.

The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.

The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.

RSS Feeds

Biotechnology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
qPCR and dPCR Markets (Instruments, Reagents, Software/Services, Clinical and Research Markets)
10/22/2014 | published by: Kalorama Information
... is mainly a workhorse in the research laboratory, while dPCR is helping to push the potential for diagnostic applications due to its sensitivity, precision, robustness and reproducibility. qPCR has been established for a broad range ...  |  read more...
USD 4,200
Anti-CD40 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD40 Antibody. This report provides information on the therapeutic development based on the Anti-CD40 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD52 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD52 Antibody. This report provides information on the therapeutic development based on the Anti-CD52 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD6 Antibody. This report provides information on the therapeutic development based on the Anti-CD6 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD80 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD80 Antibody. This report provides information on the therapeutic development based on the Anti-CD80 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD95 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD95 Antibody. This report provides information on the therapeutic development based on the Anti-CD95 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD274 (PD-L1) Antibody. This report provides information on the therapeutic development based on the Anti-CD274 (PD-L1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD279 (PD-1) Antibody. This report provides information on the therapeutic development based on the Anti-CD279 (PD-1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD3 Antibody. This report provides information on the therapeutic development based on the Anti-CD3 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD38 Antibody. This report provides information on the therapeutic development based on the Anti-CD38 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
EFT BioTech Holdings Inc - Company Capsule
11/13/2014 | published by: Canadean Ltd
... key facts, major products and services, financial ratios, key competitors, financial analysis, key employees as well as company locations and subsidiaries. Summary This report is a crucial resource for industry executives and anyone looking to ...  |  read more...
USD 99
Global Cell and Tissue Analysis Products Market 2014-2018
11/5/2014 | published by: TechNavio - Infiniti Research Ltd.
... of cells and tissues. Various biospecimen preparation, cell and tissue separation, and cell and tissue characterization products are used to isolate and assess cells and tissue. The predominant technologies used in cell and tissue analysis ...  |  read more...
USD 2,500
Anti-CS1 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CS1 Antibody. This report provides information on the therapeutic development based on the Anti-CS1 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
China Recombinant Protein Drug Industry Report, 2014-2017
11/19/2014 | published by: Research in China
... protein drugs available in Chinese sample hospitals grew at a CAGR of 19.1%, and it is projected that China will see its actual demand for recombinant protein drugs exceed RMB40 billion in 2014. The start ...  |  read more...
USD 2,500
Conference Documentation: Advances in Cell Based Assays
11/11/2014 | published by: SMI Publishing, Ltd
... and strategies to accelerate go/no-go decision making in early and clinical development. Key academic, government and industry figures cover topics encompassing: Case studies in idiopathic pulmonary fibrosis (IPF) and molecular characterisation of solid tumors Interactive ...  |  read more...
USD 788.78
Bioscience (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 240 largest Bioscience (UK) companies. The Bioscience (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
Biotechnology (UK) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... – analysing the 120 largest Biotechnology (UK) companies. The Biotechnology (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises ...  |  read more...
USD 560
Medical & Scientific Research (European) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 500 largest Medical & Scientific Research (European) companies. The Medical & Scientific Research (European) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,280
Proteomics (Global) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... the 70 largest Proteomics (Global) companies. The Proteomics (Global) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the first section thoroughly scrutinises the market ...  |  read more...
USD 1,520
Scientific Testing & Analysis (Nordic) - Industry Report
11/5/2014 | published by: Plimsoll Publishing Ltd.
... written and graphical analysis – analysing the 50 largest Scientific Testing & Analysis (Nordic) companies. The Scientific Testing & Analysis (Nordic) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their ...  |  read more...
USD 1,000
Transgene SA - Product Pipeline Review - 2014
11/14/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Transgene SA’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Nocturia - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Nocturia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Anti-CD22 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD22 Antibody. This report provides information on the therapeutic development based on the Anti-CD22 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD25 Antibody. This report provides information on the therapeutic development based on the Anti-CD25 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD4 Antibody. This report provides information on the therapeutic development based on the Anti-CD4 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9  10